Patellar Tendinitis Market Research Report - Global Forecast till 2023

Patellar Tendinitis Market Research Report - Global Forecast till 2023

ID: MRFR/HC/3698-HCRR | | Region: Global | 100 pages | Half-Cooked Research Reports

Patellar tendinitis market research report: by diagnosis (physical examination, imaging tests) treatment (corticosteroid injection, platelet-rich plasma injection, surgery, medical devices), end user (hospitals & clinics) - Global forecast till 2023  

Market Scenario


Tendons are thick cords that attach the muscles to the bones. Inflammation of these tendons is known as tendinitis. Repetitive movement, injury or diseases conditions are main causes of the tendinitis, with severe pain, swelling or tenderness at the affected area. Use of over-the-counter drugs or pain relievers such as non-steroidal anti-inflammatory drugs (NSAIDs), rest therapy and physical therapy are commonly used treatment measures for this condition. Delayed diagnosis of patellar tendinitis may require a surgery to reduce pain, and improve the movement. Tendinitis is found to be prevalent among athletes or sports players as a result of continuous strain on the tendons due to a rigorous workout, running and other activities. Moreover, patellar tendinitis is an injury to the tendon connecting kneecap (patella). The patellar tendon works with the muscles at the front of the thigh to knee. Patellar tendinitis or tendonitis is also known as jumper's knee and is most common in athletes whose sports involve frequent jumping such as basketball and volleyball. However, even people who don't participate in jumping sports can get patellar tendinitis


Increasing prevalence of sports injury, increasing investment by biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drive the growth of the market. Furthermore, favorable reimbursement policies, increased application and significant investments in the development of new technologies for the treatment of diseases are likely to fuel the market growth during the forecast period. Moreover, increasing geriatric population is boost the market growth. Established market players in the developed countries lead the globalization by pushing new products and services into the developing countries and emerging economies. However, side-effects and higher treatment cost may hinder the market growth during the forecast period.


The global patellar tendinitis market is expected to grow at a CAGR of ~8.1% during the forecast period 2017-2023.


Intended Audience



  • Pharmaceutical and Biotechnological Companies

  • Research and Development (R&D) Companies

  • Ambulatory Care Centers

  • Academic Institutes and Universities

  • Market Research and Consulting Service Providers

  • Potential Investors


Figure: Global Patellar Tendinitis Market, By Region Market Share, 2016 (%)

Patellar Tendinitis Market


Sources: Annual reports, Press release, White paper, Company presentation


Segmentations


The global patellar tendinitis market is segmented on the basis of diagnosis, treatment, and end user.


On the basis of the diagnosis, it is segmented into the physical examination, imaging tests, and others. The imaging test is further segmented into X-rays, Ultrasound, and Magnetic resonance imaging (MRI).


The treatment segment is divided into corticosteroid injection, platelet-rich plasma injection, surgery, Medical devices, and others. The medical devices are further segmented into the mechanical band, support tape, pre-cut strips, continuous rolls, and others.


Based on the end user, it is segmented into hospitals & clinics, research laboratories, and others.


Regional Analysis


The Americas dominate the global patellar tendinitis market owing to well-developed technology, increasing patient population for sports injury, high health care spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region.  


Europe holds the second position in the global patellar tendinitis market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecasted period. For instance, developed economies such as Germany and France are increasing investment in the healthcare domain and are focusing more on hospital infrastructure.     


The Asia Pacific is the fastest growing patellar tendinitis market owing to the presence of rapidly developing healthcare technology and high healthcare expenditure. Moreover, increasing patient population in countries like India and South Korea are likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare sector is projected to lead the use of advanced equipment, which, in turn, may increase the market growth in this region.   


On the other hand, the Middle East & Africa holds the least share of the market owing to less availability of funds, limited medical facilities, and deprived political conditions in Africa.


Key Players


Some of key the players in the market are Abbott (U.S.), Pfizer (U.S.), AstraZeneca (U.K), Bayer (Germany), Merck & Co. Inc. (Germany), GlaxoSmithKline plc (U.S.), Teva Pharmaceutical Industries (Israel), Boehringer Ingelheim Pharmaceuticals, Inc. (Germany), and others.


Research Methodology

Patellar Tendinitis Market 2018


Sources: Annual reports, Press release, White paper, and Company presentation

Table of Content



1. Report Prologue



2. Market Introduction



2.1 Definition



2.2 Scope of the Study



2.2.1 Research Objective



2.2.2 Assumptions



2.2.3 Limitations



3. Research Methodology



3.1 Introduction



3.2 Primary Research



3.3 Secondary research



3.4 Market Size Estimation



4. Market Dynamics



4.1 Drivers



4.2 Restrains



4.3 Opportunities



4.4 Challenges



4.5 Macroeconomic Indicators



4.6 Technology Trends & Assessment



5. Market Factor Analysis



5.1 Porters Five Forces Analysis



5.1.1 Bargaining Power of Suppliers



5.1.2 Bargaining Power of Buyers



5.1.3 Threat of New Entrants



5.1.4 Threat of Substitutes



5.1.5 Intensity of Rivalry



5.2 Value Chain Analysis



5.3 Investment Feasibility Analysis



5.4 Pricing Analysis



6. Global Patellar Tendinitis Market, by Diagnosis



6.1 Introduction



6.2 Physical Examination



6.2.1 Market Estimates & Forecast, 2017-2023



6.3 Imaging Tests



6.3.1 Market Estimates & Forecast, 2017-2023



6.4 Others



6.4.1 Market Estimates & Forecast, 2017-2023



7. Global Patellar Tendinitis Market, by Treatment



7.1 Introduction



7.2 Surgery



7.2.1 Market Estimates & Forecast, 2017-2023



7.3 Corticosteroid injection



7.3.1 Market Estimates & Forecast, 2017-2023



7.4 Platelet-rich plasma injection



7.4.1 Market Estimates & Forecast, 2017-2023



7.5 Others



7.5.1 Market Estimates & Forecast, 2017-2023



8. Global Patellar Tendinitis Market, by End User



8.1 Introduction



8.2 Hospital & Clinics



8.2.1 Market Estimates & Forecast, 2017-2023



8.3 Research Laboratories



8.3.1 Market Estimates & Forecast, 2017-2023



8.4 Others



8.4.1 Market Estimates & Forecast, 2017-2023



9. Global Patellar Tendinitis Market, by Region



9.1 Introduction



9.2 Americas



9.2.1 North America



9.2.1.1 U.S.



9.2.1.1 Canada



9.2.2 South America



9.3 Europe



9.3.1 Western Europe



9.3.1.1 Germany



9.3.1.2 France



9.3.1.3 U.K.



9.3.1.4 Italy



9.3.1.5 Spain



9.3.1.6 Rest of Western Europe



9.3.2 Eastern Europe



9.4 Asia Pacific



9.4.1 Japan



9.4.2 China



9.4.3 India



9.4.4 Australia



9.4.5 Republic of Korea



9.4.6 Rest of Asia Pacific



9.5 The Middle East & Africa



9.5.1 United Arab Emirates



9.5.2 Saudi Arabia



9.5.3 Oman



9.5.4 Kuwait



9.5.5 Qatar



9.5.6 Rest of the Middle East & Africa



10 Company Landscape



10.1 Introduction



10.2 Market Share Analysis



10.3 Key Development & Strategies



10.3.1 Key Developments



11 Company Profiles



11.1 Abbott



11.1.1 Company Overview



11.1.2 Product Overview



11.1.3 Financials



11.1.4 SWOT Analysis



11.2 Pfizer



11.2.1 Company Overview



11.2.2 Product Overview



11.2.3 Financial Overview



11.2.4 Key Developments



11.2.5 SWOT Analysis



11.3 AstraZeneca



11.3.1 Company Overview



11.3.2 Product Overview



11.3.3 Financial Overview



11.3.4 Key Development



11.3.5 SWOT Analysis



11.4 Bayer



11.4.1 Company Overview



11.4.2 Product/Business Segment Overview



11.4.3 Financial Overview



11.4.4 Key Development



11.4.5 SWOT Analysis



11.5 Merck & Co. Inc



11.5.1 Company Overview



11.5.2 Product Overview



11.5.3 Financial overview



11.5.4 Key Developments



11.6 GlaxoSmithKline plc



11.6.1 Company Overview



11.6.2 Product Overview



11.6.3 Financial Overview



11.6.4 Key Developments



11.7 Teva Pharmaceutical Industries



11.7.1 Overview



11.7.2 Product Overview



11.7.3 Financials



11.7.4 Key Developments



11.7.5 SWOT Analysis



11.8 Others



12 MRFR Conclusion



12.1 Key Findings



12.1.1 From CEO’s View Point



12.1.2 Unmet Needs of the Market



12.2 Key Companies to Watch



12.3 Prediction of Patellar Tendinitis Industry



13 Appendix





LIST OF TABLES



Table 1 Patellar Tendinitis Industry Synopsis, 2017-2023



Table 2 Global Patellar Tendinitis Market Estimates and Forecast, 2017-2023, (USD Million)



Table 3 Global Patellar Tendinitis Market by Region, 2017-2023, (USD Million)



Table 4 Global Patellar Tendinitis Market by Diagnosis, 2017-2023, (USD Million)



Table 5 Global Patellar Tendinitis Market by Treatment, 2017-2023, (USD Million)



Table 6 Global Patellar Tendinitis Market by End Users, 2017-2023, (USD Million)



Table 7 North America Patellar Tendinitis Market by Diagnosis, 2017-2023, (USD Million)



Table 8 North America Patellar Tendinitis Market by Treatment, 2017-2023, (USD Million)



Table 9 North America Patellar Tendinitis Market by End Users, 2017-2023, (USD Million)



Table 10 U.S. Patellar Tendinitis Market by Diagnosis, 2017-2023, (USD Million)



Table 11 US Patellar Tendinitis Market by Treatment, 2017-2023, (USD Million)



Table 12 US Patellar Tendinitis Market by End Users, 2017-2023, (USD Million)



Table 13 Canada Patellar Tendinitis Market by Diagnosis, 2017-2023, (USD Million)



Table 14 Canada Patellar Tendinitis Market by Treatment, 2017-2023, (USD Million)



Table 15 Canada Patellar Tendinitis Market by End Users, 2017-2023, (USD Million)



Table 16 South America Patellar Tendinitis Market by Diagnosis, 2017-2023, (USD Million)



Table 17 South America Patellar Tendinitis Market by Treatment, 2017-2023, (USD Million)



Table 18 South America Patellar Tendinitis Market by End Users, 2017-2023, (USD Million)



Table 19 Europe Patellar Tendinitis Market by Diagnosis, 2017-2023, (USD Million)



Table 20 Europe Patellar Tendinitis Market by Treatment, 2017-2023, (USD Million)



Table 21 Europe Patellar Tendinitis Market by End Users, 2017-2023, (USD Million)



Table 22 Western Europe Patellar Tendinitis Market by Diagnosis, 2017-2023, (USD Million)



Table 23 Western Europe Patellar Tendinitis Market by Treatment, 2017-2023, (USD Million)



Table 24 Western Europe Patellar Tendinitis Market by End Users, 2017-2023, (USD Million)



Table 25 Eastern Europe Patellar Tendinitis Market by Diagnosis, 2017-2023, (USD Million)



Table 26 Eastern Europe Patellar Tendinitis Market by Treatment, 2017-2023, (USD Million)



Table 27 Eastern Europe Patellar Tendinitis Market by End Users, 2017-2023, (USD Million)



Table 28 Asia Pacific Patellar Tendinitis Market by Diagnosis, 2017-2023, (USD Million)



Table 29 Asia Pacific Patellar Tendinitis Market by Treatment, 2017-2023, (USD Million)



Table 30 Asia Pacific Patellar Tendinitis Market by End Users, 2017-2023, (USD Million)



Table 31 Middle East & Africa Patellar Tendinitis Market by Diagnosis, 2017-2023, (USD Million)



Table 32 Middle East & Africa Patellar Tendinitis Market by Treatment, 2017-2023, (USD Million)



Table 33 Middle East & Africa Patellar Tendinitis Market by End Users, 2017-2023, (USD Million)





LIST OF FIGURES



Figure 1 Research Process



Figure 2 Segmentation for Global Patellar Tendinitis Market



Figure 3 Segmentation Market Dynamics for Patellar Tendinitis Market



Figure 4 Global Patellar Tendinitis Market Share, by Diagnosis 2016



Figure 5 Global Patellar Tendinitis Market Share, by Treatment 2016



Figure 6 Global Patellar Tendinitis Market Share, by End Users, 2016



Figure 7 Global Patellar Tendinitis Market Share, by Region, 2016



Figure 8 North America Patellar Tendinitis Market Share, by Country, 2016



Figure 9 Europe Patellar Tendinitis Market Share, by Country, 2016



Figure 10 Asia Pacific Patellar Tendinitis Market Share, by Country, 2016



Figure 11 Middle East & Africa Patellar Tendinitis Market Share, by Country, 2016



Figure 12 Global Patellar Tendinitis Market: Company Share Analysis, 2016 (%)



Figure 13 Abbott: Key Financials



Figure 14 Abbott: Segmental Revenue



Figure 16 Abbott: Geographical Revenue



Figure 17 Pfizer. Key Financials



Figure 18 Pfizer. Segmental Revenue



Figure 19 Pfizer. Geographical Revenue



Figure 20 AstraZeneca. Key Financials



Figure 21 AstraZeneca. Segmental Revenue



Figure 22 AstraZeneca: Geographical Revenue



Figure 23 Bayer: Key Financials



Figure 24 Bayer: Segmental Revenue



Figure 25 Bayer: Geographical Revenue



Figure 26 Merck & Co. Inc: Key Financials



Figure 27 Merck & Co. Inc: Segmental Revenue



Figure 28 Merck & Co. Inc: Geographical Revenue



Figure 29 GlaxoSmithKline plc: Key Financials



Figure 30 GlaxoSmithKline plc: Segmental Revenue



Figure 31 GlaxoSmithKline plc: Geographical Revenue